Cardiology's Final Frontier: Confronting CTO
For the past four years, Karmpaliotis has devoted much time to the retrograde and antegrade angioplasty, a procedure that can take four times as long as a stent. Since January, he and his team have performed 80 such procedures, with an established success rate of 89%, significantly more than significantly more than the national average of 65%, according to the hospital.
"Developments in guidewire technology, imaging technique, and coronary devices have contributed to the improved prognosis of patients affected by a CTO lesion," according to Current Cardiology Reports, in which "Enhancement in antegrade and retrograde techniques" also result in improved outcomes, the report stated.
Cardiac Interventions Today in 2008 described the strategies for confronting chronic occluded arteries as "conquering the last frontier of interventional cardiology."
The presence of CTOs often result in open heart surgery, though Karmpaliotis believes antegrade or retrograde angioplasty should be considered increasingly as a proper alternative option in carefully selected cases; to relieve a patient, too, of symptoms of angina, shortness of breath or compromised heart function.
In recent years, there has been much debate about the procedure in this country.
- Two-Midnight Rule Must be Fixed or Replaced, Say Providers
- CDC Warns of Antibiotic Overuse in Hospitals
- Care Coordination Tough to Define, Measure
- Don't Underestimate Emotional Intelligence
- HIMSS: Software Bugs, Shifting Alliances Unsettling for CIOs
- The Secret to Physician Engagement? It's Not Better Pay
- SCOTUS Review of NC Board Case 'A Very Big Deal' to Providers
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- AHRQ: Surgical Admissions Bring 48% of Hospital Revenue
- Yale New Haven Health Partners with Tenet Healthcare in CT